Ohio Board of Pharmacy places temporary ban on opioid-like kratom products - WCPO 9 News
Ohio Board of Pharmacy has placed a temporary ban on kratom products that mimic opioid effects, effective immediately.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 28, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All pharmacies in Ohio, including independent, retail chain, compounding, and long-term-care pharmacies. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate; no grace period.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Kratom products with opioid-like effects are now temporarily banned from sale, distribution, or dispensing in Ohio.
Who it affects
All pharmacies in Ohio, including independent, retail chain, compounding, and long-term-care pharmacies.
What you must do
Immediately cease sale and remove from shelves any kratom products that have opioid-like effects.
Deadline
Immediate; no grace period.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Texas House passes bill allowing ivermectin without prescription - cbs19.tv
- House committee passes bill that would allow Texas pharmacists to give ivermectin without prescription - cbs19.tv
- Pharmacy technicians must register with Florida's Board of Pharmacy by Jan. 1, 2010 - Drug Topics
- Judge Trims DEA's Suspension Of Fla. Pharmacy's Permits - Law360
- New Wisconsin Law Regulates PBM and Other Stakeholders Involved in Drug Pricing - Quarles